I had not seen this so share it (my precis).
More than 700,000 AstraZeneca doses 'secretly' flown to Australia from Britain
8 Apr 2021 (
The Sydney Morning Herald)
Australia’s vaccine rollout was helped by 717,000 AZ doses manufactured in the UK rather than from factories in Europe as widely inferred. The need to source jabs from the UK underscores the difficulties Australia and AZ have faced in extracting supply from the EU under the bloc’s tough export controls. Not a single AZ dose has been exported to Australia from Europe (31 Mar). The first 300,000 UK-made doses landed at Sydney on 28 Feb. Another batch from UK arrived in March, after Italy and the European Union blocked the export of 250,000 doses.
UK has sent vaccines to its overseas territories such as Gibraltar and the Falkland Islands. Who knows which other countries, besides Australia, have received AZ vaccines made in British factories? The UK has domestic production capacity, but its early programme was reliant on vaccine imports from Europe. The UK also received 5M AZ doses from SII Puna, India in March.
Australia had received (Q1) more than one million doses of Pfizer vaccines from the EU. AZ had told Australia it could only provide 1.2M doses in Q1 instead of the expected 3.8M. However only 717,000 doses – the ones from the UK – had arrived (@31 Mar). AZ is producing the vaccine at no-profit for the duration of the pandemic.
More than 50 million AZ doses will be made 'domestically' in
Melbourne ( CSL-Behring Australia and Seqirus) under licence from AZ in 2021 however only 1.3M of the forecast 2M doses were released by 31 March (expected 1M a week from April onwards). Most of the early vaccine supply (?1M but reports vary) was sent to Papua New Guinea (another ex-British colony).
Comments:
1) By 1 May Australia had given a first vaccine to about 2M people so this points to CSL production not ramping up as well as they'd hoped. This experience of difficulty reflects that of the plants in Europe and the UK.
2) I am surprised, given the reported capacity of the two AZ plants in UK, that the UK vaccination programme roll-out has been hampered by lack of supply, unless a proportion is being exported (not to the EU).